Back to Search
Start Over
Assessment of the functional and health-related needs of patients with metastatic breast cancer prior to initiation of cancer treatment.
- Source :
-
Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Jan 06. Date of Electronic Publication: 2025 Jan 06. - Publication Year :
- 2025
- Publisher :
- Ahead of Print
-
Abstract
- Purpose: To identify needs of metastatic breast cancer patients prior to starting a new systemic treatment.<br />Methods: Fifty patients with newly diagnosed, recurrent, or progressive metastatic breast cancer completed an electronic survey which included patient-reported outcome measures of function (PROMIS Cancer Function Brief 3D profile), quality of life (FACT-G), exercise (Godin Leisure-Time exercise questionnaire), and diet (REAP-S); demographic information; and self-reported use of or referral to specific resources at the cancer center prior to beginning a new systemic oncologic treatment.<br />Results: Prior to starting a new treatment for metastatic breast cancer, patients reported mild functional impairment (PROMIS Cancer Function Brief 3D profile mean score:42.1) and low quality of life (FACT-G: 50%) along with low diet quality (REAP-S mean score: 29). Fifty-two percent of patients were sedentary (Godin Leisure-Time exercise questionnaire) and major barriers to exercise were pain (38%) and fatigue (34%); however, patients expressed a high level of interest (86%) in improving their ability to tolerate cancer treatment by addressing these areas.<br />Conclusion: Patients with new or recurrent metastatic breast cancer face health-related issues including sedentary behavior, poor diet, and limitations including pain and fatigue that can be addressed in prehabilitative efforts prior to starting a new oncologic treatment.<br />Competing Interests: Declarations. Conflict of interest: SEK received unrelated speaker honorarium from Harvard Medical School. Ethical approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the institutional review board at the University of North Carolina.<br /> (© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Details
- Language :
- English
- ISSN :
- 1573-7217
- Database :
- MEDLINE
- Journal :
- Breast cancer research and treatment
- Publication Type :
- Academic Journal
- Accession number :
- 39762707
- Full Text :
- https://doi.org/10.1007/s10549-024-07590-6